Cargando…
Current status of adjuvant chemotherapy for gastric cancer
Although radical gastrectomy is a standard treatment for advanced gastric cancer, recurrence remains high. After several large-scale controlled studies have shown the beneficial effects of adjuvant chemotherapy, that treatment emerged as a standard option for advanced gastric cancer after gastrectom...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755106/ https://www.ncbi.nlm.nih.gov/pubmed/31558973 http://dx.doi.org/10.4251/wjgo.v11.i9.679 |
_version_ | 1783453160753332224 |
---|---|
author | Kim, In-Hwan |
author_facet | Kim, In-Hwan |
author_sort | Kim, In-Hwan |
collection | PubMed |
description | Although radical gastrectomy is a standard treatment for advanced gastric cancer, recurrence remains high. After several large-scale controlled studies have shown the beneficial effects of adjuvant chemotherapy, that treatment emerged as a standard option for advanced gastric cancer after gastrectomy. However, various guidelines from different countries have suggested different adjuvant chemotherapies. Understanding the differences between guidelines is very important for investigating further therapeutic strategies. Fortunately, because there are many ongoing studies about new regimens for adjuvant treatment, it is expected that patients with gastric cancer after surgery will have better outcome. |
format | Online Article Text |
id | pubmed-6755106 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-67551062019-09-26 Current status of adjuvant chemotherapy for gastric cancer Kim, In-Hwan World J Gastrointest Oncol Review Although radical gastrectomy is a standard treatment for advanced gastric cancer, recurrence remains high. After several large-scale controlled studies have shown the beneficial effects of adjuvant chemotherapy, that treatment emerged as a standard option for advanced gastric cancer after gastrectomy. However, various guidelines from different countries have suggested different adjuvant chemotherapies. Understanding the differences between guidelines is very important for investigating further therapeutic strategies. Fortunately, because there are many ongoing studies about new regimens for adjuvant treatment, it is expected that patients with gastric cancer after surgery will have better outcome. Baishideng Publishing Group Inc 2019-09-15 2019-09-15 /pmc/articles/PMC6755106/ /pubmed/31558973 http://dx.doi.org/10.4251/wjgo.v11.i9.679 Text en ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Review Kim, In-Hwan Current status of adjuvant chemotherapy for gastric cancer |
title | Current status of adjuvant chemotherapy for gastric cancer |
title_full | Current status of adjuvant chemotherapy for gastric cancer |
title_fullStr | Current status of adjuvant chemotherapy for gastric cancer |
title_full_unstemmed | Current status of adjuvant chemotherapy for gastric cancer |
title_short | Current status of adjuvant chemotherapy for gastric cancer |
title_sort | current status of adjuvant chemotherapy for gastric cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755106/ https://www.ncbi.nlm.nih.gov/pubmed/31558973 http://dx.doi.org/10.4251/wjgo.v11.i9.679 |
work_keys_str_mv | AT kiminhwan currentstatusofadjuvantchemotherapyforgastriccancer |